New Products

View all new products by date added

Search for new products by date added, alphabetically, or by pharmacological action.

New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the symbol.

If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.

Cat No Product Name / Activity Date Added
6048 R-BC154 Aug 2017
High affinity fluorescent α4β1 /α9β1 inhibitor; mobilizes HSCs
6119 OB 24 hydrochloride Aug 2017
Potent and selective heme oxygenase 1 (HO-1) inhibitor
6049 PF 04937319 Aug 2017
Glucokinase partial activator
6196 Brequinar sodium Aug 2017
Potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor
6230 Rucaparib camsylate Aug 2017
PARP inhibitor
6098 Lalistat 1 Aug 2017
Potent and selective lysosomal acid lipase (LAL) inhibitor
6289 JH-II-127 Aug 2017
Potent and selective LRRK2 inhibitor
5705 M62812 Aug 2017
TLR-4 inhibitor
5818 NVP BSK 805 Aug 2017
Potent JAK2 inhibitor; orally bioavailable
6038 SR 10067 Aug 2017
Selective Rev-Erbα/β agonist; anxiolytic
6299 MS 15203 Aug 2017
Potent and selective GPR171 partial agonist
6278 JNJ 55511118 Aug 2017
Selective, high affinity negative modulator of AMPA receptors containing TARP-γ8
6193 AM 4113 Aug 2017
Selective, high affinity CB1 antagonist
6116 BHPI Aug 2017
ERα antagonist; also activates unfolded protein response; active in vivo
6231 Dacomitinib Jul 2017
Potent irreversible pan ErbB inhibitor
6265 Lonafarnib Jul 2017
Potent farnesyl transferase inhibitor
6167 A 196 Jul 2017
Potent and selective SUV420H1/H2 inhibitor
5768 HS 38 Jul 2017
ATP-competitive inhibitor of DAPK and ZIPK
6078 BPTU Jul 2017
P2Y1 allosteric antagonist
6016 IN 1130 Jul 2017
Potent and selective inhibitor of TGF-βRI
6045 NITD 008 Jul 2017
Antiviral; selective flavivirus inhibitor
6317 Prasugrel Jul 2017
Irreversible P2Y12 antagonist; antiplatelet and orally active
6306 BigLEN (rat) Jul 2017
Potent GPR171 agonist
6304 BigLEN (mouse) Jul 2017
GPR171 agonist
6292 ELARR>GG Jul 2017
Negative control for ELA-32 (Cat.No.6291).
6291 ELA-32 (human) Jul 2017
Potent, high affinity apelin receptor agonist; stimulates angiogenesis
6191 TH 1020 Jul 2017
Toll-like receptor (TLR) 5/Flagellin complex antagonist
6165 AC 265347 Jul 2017
CaSR biased allosteric modulator
6287 st-Ht31 P Jul 2017
Negative control for st-Ht31 (Cat. No. 6286)
6286 st-Ht31 Jul 2017
Inhibits PKA/AKAP interactions; cell permeable
5658 AR-C 141990 hydrochloride Jul 2017
MCT1 inhibitor
6128 GSK 343 Jun 2017
Potent and selective SAM-competitive EZH2 inhibitor
6270 Tubastatin A hydrochloride Jun 2017
Potent HDAC6 inhibitor
6303 Parathyroid hormone (1-34) (bovine) Jun 2017
Parathyroid hormone (PTH) receptor agonist.
6301 Parathyroid hormone (1-34) (rat) Jun 2017
Parathyroid hormone (PTH) receptor agonist
6288 Peptide YY (3-36) human Jun 2017
NPY Y2 receptor agonist
6284 BRD 73954 Jun 2017
Dual histone deacetylase (HDAC) 6/8 inhibitor
6208 MS 275 Jun 2017
HDAC (Class I) inhibitor
6073 P21d hydrochloride Jun 2017
Potent and selective Brk inhibitor
6282 BRD 4770 Jun 2017
G9a inhibitor and S-adenosyl methionine mimetic; cell permeable
6302 Pomalidomide Jun 2017
Cereblon ubiquitination inhibitor; also TNFα inhibitor and antiangiogenic
6294 ELA-14 negative control Jun 2017
Negative control for ELA-14 (Cat.No.6293).
6293 ELA-14 (human) Jun 2017
Potent apelin (APJ) receptor agonist
6189 Myricetin Jun 2017
Irreversible TrxR inhibitor
4930 UNC 2399 Jun 2017
Biotinylated UNC 1999 (Cat.No. 4904)
5103 Lys-CoA Jun 2017
Selective p300 inhibitor
6277 7α,25-Dihydroxycholesterol Jun 2017
Highly potent GPR183 (EBI2) agonist
6194 TM 5441 Jun 2017
Plasminogen activator inhibitor-1 (PAI-1) inhibitor
6185 Pemetrexed Jun 2017
High affinity dihydrofolate reductase inhibitor; also inhibits thymidylate synthase, GARFT and AICART
6174 CVT 313 Jun 2017
cdk2 inhibitor
6305 Lenalidomide Jun 2017
Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligase
4322 JH 295 May 2017
Irreversible Nek2 inhibitor
5343 TPPB May 2017
High affinity PKC activator; also APP modulator
6181 OTX 015 May 2017
BET bromodomain inhibitor; orally bioavailable
6258 CC 401 dihydrochloride May 2017
High affinity JNK inhibitor; also inhibits HCMV replication
6311 Tadalafil May 2017
Potent and highly selective PDE5 inhibitor; orally bioavailable
6271 ST 034307 May 2017
Adenylyl cyclase 1 (AC1) inhibitor; analgesic and active in vivo
6012 OXSI 2 May 2017
Potent Syk kinase inhibitor; also inhibits assembly of NLRP3 inflammasomes
5150 NCL 00017509 May 2017
Potent and reversible NIMA related kinase 2 (Nek2) inhibitor
5675 AZ PFKFB3 26 May 2017
Potent and selective PFKFB3 inhibitor
5821 C-DIM 12 May 2017
Nurr1 activator; inhibits NF-κB-dependent gene expression
6060 AZD 2461 May 2017
Potent PARP inhibitor; orally bioavailable
5921 D9 May 2017
Potent thioredoxin reductase (TrxR) inhibitor
6036 STK16-IN-1 May 2017
Serine/threonine protein kinase 16 (STK16) inhibitor; also inhibits PI 3Kδ, PI 3Kγ and mTOR kinases.
6285 Megestrol Acetate May 2017
Synthetic progesterone analog
6121 NB-caged Tyrosine hydrochloride May 2017
ortho-nitrobenzyl caged L- tyrosine
5372 Bioymifi May 2017
DR5 (TRAIL receptor) agonist; induces apoptosis
5842 MK 386 May 2017
Potent, selective human type 1 5α-reductase inhibitor
5826 LEI 101 hydrochloride May 2017
Potent and selective CB2 partial agonist; orally biovailable
5888 MOPSO, free acid May 2017
Buffer; working pH range in aqueous solution: 6.2-7.6
6061 XMD 8-87 May 2017
Potent Ack1/TNK2 inhibitor
3974 Latrunculin B May 2017
Inhibitor of actin polymerization
5452 SKI 178 May 2017
Non-lipid sphingosine kinase 1 (SphK1) inhibitor
5963 CMPI hydrochloride May 2017
Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs
6100 Fasentin May 2017
GLUT1/GLUT4 inhibitor; also Fas-sensitizer
6158 (S)-Equol May 2017
Potent estrogen receptor β (ERβ) agonist; dihydrotestosterone antagonist
6215 H3K4(Me2) (1-20) May 2017
Histone H3 peptide
6259 RAGE antagonist peptide May 2017
Receptor for advanced glycation end products (RAGE) antagonist
6183 Nanchangmycin May 2017
Antiviral; active against Zika, West Nile and dengue viruses
6152 LDN 214117 Apr 2017
Potent and selective ALK2 inhibitor
6164 SEA 0400 Apr 2017
Potent Na+/Ca2+ exchanger (NCX) inhibitor.
5700 ML 315 hydrochloride Apr 2017
Inhibitor of Clk and DYRK kinases
5741 25-Hydroxycholesterol Apr 2017
Antiviral; also α-crystallin (cryAB) chaperone
6151 LDN 212854 Apr 2017
Potent bone morphogenetic protein type I (ALK) inhibitor
5933 Tocriscreen Kinase Inhibitor Toolbox I Apr 2017
A library of 80 kinase inhibitor compounds (250 μL 10 mM DMSO solutions)
6175 DBHDA Apr 2017
Reagent for synthetic biology; converts cysteine to dehydroalanine
6268 Tocriscreen Kinase Inhibitor Toolbox I & II Apr 2017
A library of 160 kinase inhibitor compounds (250 μL 10 mM DMSO solutions)
6225 Tocriscreen Kinase Inhibitor Toolbox II Apr 2017
A library of 80 kinase inhibitor compounds (250 μL 10 mM DMSO solutions)
6218 Galiellalactone Apr 2017
STAT3 inhibitor; active in vivo
6219 Arformoterol tartrate Apr 2017
Long-acting β2 agonist (LABA)
6217 Histone H3 (1-34) Apr 2017
Histone H3 peptide
6161 Ailanthone Apr 2017
Potent inhibitor of androgen receptor (AR)
5729 TASP 0390325 Apr 2017
Potent and selective V1B receptor antagonist; orally bioavailable
5976 Ned K Apr 2017
NAADP signaling inhibitor
6155 cis MZ 1 Apr 2017
Negative Control for MZ1
6213 H3K27(Me3) (15-34) Apr 2017
Histone H3 peptide; substrate for methyltransferase/demethylase enzymes
6156 VH 298 Apr 2017
High-affinity inhibitor of VHL
6227 TAT-Gap19 Apr 2017
Cx43 hemichannel blocker
6212 H3K27(Me2) (15-34) Apr 2017
Histone H3 peptide; substrate for methyltransferase/demethylase enzymes
6190 Retrobradykinin Apr 2017
Reverse analog of Bradykinin
6216 H3K4(Me3) (1-20) Apr 2017
Histone H3 peptide; substrate for methyltransferase/demethylase enzymes
6214 H3K4(Me) (1-20) Apr 2017
Histone H3 peptide; substrate for methyltransferase/demethylase enzymes
6211 H3K27(Me) (15-34) Apr 2017
Histone H3 peptide; substrate for demethylase/methyltransferase enzymes
6157 cis VH 298 Apr 2017
Negative control for VH 298
6154 MZ 1 Apr 2017
(+)-JQ1 based PROTAC that selectively degrades BRD4 in cells
6009 B I09 Apr 2017
IRE1 endonuclease inhibitor; cell permeable
5987 (±)-ML 209 Apr 2017
RORγt inverse agonist; suppresses Th17 cell differentiation
6202 Vilazodone hydrochloride Apr 2017
Potent 5-HT1A partial agonist and SSRI; antidepressant
6188 Everolimus Apr 2017
mTOR inhibitor;immunosuppressant
6168 RI 1 Apr 2017
RAD51 recombinase inhibitor
6149 PA Janelia Fluor® 549, SE Apr 2017
Photoactivatable cell permeable fluorescent dye; supplied as NHS ester
6253 F 127 (20% solution in DMSO) Apr 2017
Nonionic detergent
6234 Entecavir Apr 2017
Potent and selective hepatitis B virus inhibitor
6180 NMS 873 Apr 2017
Potent and selective p97 ATPase (VCP) allosteric inhibitor
6150 PA Janelia Fluor® 646, SE Apr 2017
Photoactivatable cell permeable fluorescent dye; supplied as NHS ester
5437 Cyanine 7, SE Mar 2017
Near-infrared fluorescent dye for labeling of amines
5435 Cyanine 3, SE Mar 2017
Orange fluorescent dye for labeling of amines
5865 KLH 45 Mar 2017
Potent DDHD2 inhibitor
6105 TC AC 28 Mar 2017
High affinity BET bromodomain ligand
6264 Caerulein Mar 2017
CCK agonist
6221 PKI (5-24) Mar 2017
High affinity PKA inhibitor
6171 MLS 1547 Mar 2017
G protein-biased D2 receptor partial agonist
6092 TDZD 8 Mar 2017
Selective non-ATP competitive inhibitor of GSK 3β
6250 Filipin III Mar 2017
Polyene antibiotic; inhibits formation of pathological isoform of prion protein
6233 Retigabine Mar 2017
KV7 channel activator
5407 GA3-AM Mar 2017
Gibberellin-analog (GA3) chemical dimerizer; cell permeable
5758 AGN 193109 Mar 2017
High affinity pan-RAR antagonist
5720 AR-C 69931 tetrasodium salt Mar 2017
Highly potent P2Y12 antagonist
6086 AMP PNP Mar 2017
Kir6 blocker; non-hydrolyzable AMP analog
5932 Tocriscreen Library of FDA-Approved Compounds Mar 2017
A library of 160 FDA-approved compounds (250 μL 10 mM DMSO solutions)
6146 LAP Mar 2017
Photocrosslinker for hydrogels
6047 BOP Mar 2017
Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs
6232 Bosentan Mar 2017
High affinity dual ETA and ETB receptor antagonist;orally bioavailable
6210 ci-IP3/PM Mar 2017
Caged inositol triphosphate
6204 7-Ethoxyresorufin Mar 2017
Fluorometric CYP450 substrate
6107 CP 424174 Mar 2017
Inhibitor of IL-1β post-translational processing; indirectly inhibits NLRP3
5300 BI 605906 Mar 2017
Selective IKKβ inhibitor
5872 AZ 10397767 Mar 2017
Potent CXCR2 antagonist
6138 SR 9243 Mar 2017
Selective LXR inverse agonist
5419 PCNA I1 Feb 2017
PCNA inhibitor
5672 GSK 319347A Feb 2017
Potent and selective IKKε inhibitor
5873 CAPS Feb 2017
Buffer widely used in Western blotting
5785 MDNI-caged-L-glutamate Feb 2017
Stable photoreleaser of L-glutamate
5881 Bicine Feb 2017
General purpose buffer
5846 IT 901 Feb 2017
NF-κB c-Rel subunit inhibitor
5986 NAV 2729 Feb 2017
Selective ARF6 inhibitor
5879 ACES Feb 2017
Zwitterionic buffer
6088 SB 3CT Feb 2017
Selective high affinity MMP2 inhibitor
6101 SHIP 2a Feb 2017
Cystathione γ lyase (CSE) inhibitor
6176 FTY 720 Feb 2017
Potent S1P receptor agonist; also immunosuppressant
6170 Cinacalcet hydrochloride Feb 2017
Calcium-sensing receptor (CaSR) allosteric agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailable
5850 HM 50316 Feb 2017
High affinity FABP4 inhibitor